CureVac NV (CVAC)
2.685
-0.06
(-2.19%)
USD |
NASDAQ |
Nov 14, 16:00
2.73
+0.04
(+1.68%)
After-Hours: 20:00
CureVac Total Assets (Quarterly): 596.87M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 596.87M |
| March 31, 2024 | 745.60M |
| December 31, 2023 | 871.33M |
| September 30, 2023 | 891.86M |
| June 30, 2023 | 977.50M |
| March 31, 2023 | 1.062B |
| December 31, 2022 | 922.77M |
| September 30, 2022 | 894.93M |
| June 30, 2022 | 967.10M |
| Date | Value |
|---|---|
| March 31, 2022 | 1.146B |
| December 31, 2021 | 1.311B |
| September 30, 2021 | 1.929B |
| June 30, 2021 | 2.143B |
| December 31, 2020 | 1.859B |
| September 30, 2020 | 1.200B |
| March 31, 2020 | 171.68M |
| December 31, 2019 | 146.32M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
146.32M
Minimum
Dec 2019
2.143B
Maximum
Jun 2021
1.049B
Average
967.10M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| BioNTech SE | 25.02B |
| Bayer AG | 128.48B |
| Affimed NV | 57.00M |
| InflaRx NV | 99.73M |
| Immatics NV | 672.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 193.27M |
| Shareholders Equity (Quarterly) | 403.61M |
| Current Ratio | 2.287 |